REEVE GRAHAM D.
Known title: COOCIK: 0001519948
Associated companies
Transaction History
| USPH | ▼ Sell | Tax Withholding | 762 | $59K | 8/20/2026 | View on chart |
| USPH | ▼ Sell | Tax Withholding | 762 | $47K | 5/20/2026 | View on chart |
| USPH | ▼ Sell | Open Market | 662 | $52K | 3/11/2026 | View on chart |
| USPH | ▼ Sell | Open Market | 1 | $79 | 3/9/2026 | View on chart |
| USPH | ▼ Sell | Open Market | 1,807 | $149K | 3/6/2026 | View on chart |
| USPH | ▲ Buy | Grant | 10,000 | $0 | 2/23/2026 | View on chart |
| USPH | ▼ Sell | Open Market | 743 | $53K | 11/24/2025 | View on chart |
| USPH | ▼ Sell | Open Market | 763 | $65K | 8/21/2025 | View on chart |
| USPH | ▼ Sell | Open Market | 1,792 | $155K | 8/11/2025 | View on chart |
| USPH | ▼ Sell | Open Market | 530 | $41K | 5/21/2025 | View on chart |
| USPH | ▼ Sell | Open Market | 1,730 | $142K | 3/7/2025 | View on chart |
| USPH | ▲ Buy | Grant | 8,100 | $0 | 2/24/2025 | View on chart |
| USPH | ▼ Sell | Open Market | 1,724 | $166K | 11/8/2024 | View on chart |
| USPH | ▼ Sell | Open Market | 1,724 | $142K | 8/21/2024 | View on chart |
| USPH | ▼ Sell | Open Market | 1,724 | $182K | 5/10/2024 | View on chart |
| USPH | ▼ Sell | Open Market | 2,629 | $274K | 3/4/2024 | View on chart |
| USPH | ▲ Buy | Grant | 8,100 | $0 | 2/26/2024 | View on chart |
| USPH | ▼ Sell | Open Market | 1,500 | $131K | 11/15/2023 | View on chart |
| USPH | ▼ Sell | Open Market | 4,114 | $452K | 8/11/2023 | View on chart |
| USPH | ▼ Sell | Open Market | 1,912 | $193K | 3/2/2023 | View on chart |
| USPH | ▲ Buy | Grant | 5,000 | $0 | 2/20/2023 | View on chart |
| USPH | ▼ Sell | Open Market | 1,909 | $162K | 11/7/2022 | View on chart |
| USPH | ▼ Sell | Open Market | 3,818 | $352K | 8/8/2022 | View on chart |
| USPH | ▲ Buy | Grant | 10,000 | $0 | 3/11/2022 | View on chart |
| USPH | ▼ Sell | Open Market | 2,118 | $192K | 2/28/2022 | View on chart |
| USPH | ▼ Sell | Open Market | 1,000 | $94K | 12/6/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
USPH Appoints New CFO and Board Member Amid Earnings Review
U.S. Physical Therapy announced the appointment of a new Chief Financial Officer and a new board member, Myra Davis. These leadership changes are occurring alongside the release of the company's Q2 2026 earnings call transcript. The news has drawn attention to potential shifts in the company's cash flow management and financial narrative.
USPH Appoints New CFO and Board Member Amid Earnings Review. U.S. Physical Therapy announced the appointment of a new Chief Financial Officer and a new board member, Myra Davis. These leadership changes are occurring alongside the release of the company's Q2 2026 earnings call transcript. The news has drawn attention to potential shifts in the company's cash flow management and financial narrative.